The Board of Directors in their meeting held on November 03, 2026 have approved the financial results for the quarter and Half year ended September 30, 2026

November 03, 2026 The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: VIJAYA BSE Scrip Code: 543350 Dear Sir/Madam, Subject: Outcome of the Board Meeting held on Tuesday, November 03, 2026 Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e., Tuesday, November 03, 2026, has inter-alia considered and approved the following: 1. Unaudited Financial Results of the Company for the second quarter ended September 30, 2026 In terms of the above, we enclose herewith the following: a) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026; and b) Limited review Reports on the Standalone & Consolidated Financial Results for quarter and half year ended September 30, 2026. 2. Appointment of Mr. Rahul Jain as a Company Secretary and Compliance officer (Key Managerial Personnel) of the Company Based on the recommendation of the Nomination and Remuneration Committee, the Board has appointed Mr. Rahul Jain (Membership No. ACS A62949) as Company Secretary and Compliance Officer pursuant to Section 203 of the Companies Act 2013 and Regulation 6(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 with effect from November 03, 2026. Details with respect to Change in Key Managerial Personnel (Appointment of Company Secretary and Compliance Officer) as required under Regulation 30 read with Part A of Schedule III of the SEBI Listing Regulations and read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, as amended is provided in Annexure A. The Board Meeting commenced at 06 :12 P.M. (IST) and concluded at 06:40 P.M.(IST). Kindly take the same on record. Thanking You. Yours faithfully, For Vijaya Diagnostic Centre Limited Narasimha Raju K A Chief Financial Officer Encl.: As above ANNEXURE A Particulars required as per Regulation 30 of SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015 read with SEBI Circular No. HO/49/14/14(7)2025- CFD- POD2/I/3762/2026 dated 30th January, 2026 are given below; Sr. Details of events that need to be Information of such event No. provided 1. Reason for Change viz. appointment, Appointment of Mr. Rahul Jain, as the Company resignation, removal, death or Secretary and Compliance Officer designated as otherwise; Key Managerial Personnel of the Company. 2. Date of Appointment/Cessation & term November 3, 2026 of Appointment/ Re- appointment; 3. Brief profile (in case of appointment); Mr. Rahul Jain is a qualified Company Secretary and an Associate Member of the Institute of Company Secretaries of India (ICSI). He has over six years of professional experience in the field of corporate secretarial functions, Corporate Governance and regulatory compliances, with extensive exposure to the regulatory framework applicable to listed companies. His areas of expertise include the Companies Act, 2013, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, SEBI (Prohibition of Insider Trading) Regulations, 2015, SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, FEMA and other applicable regulatory requirements. He has experience in managing Board and shareholders' meetings, corporate restructuring, preferential allotments, FCCB issuances, ESOPs, share capital restructuring, regulatory disclosures, stock exchange compliances and corporate governance matters. 4. Disclosure of relationships between Not applicable directors (in case of appointment of a director) B S R and Co Salarpuria Knowledge City, Orwell B Wing, 6th Floor, Unit-3, Sy No. 83/1 Plot No. 02, Raidurg Chartered Accountants Hyderabad – 500 081, India Telephone + 91 407 182 2000 Fax + 91 407 182 2399 Limited Review Report on unaudited standalone financial results of Vijaya Diagnostic Centre Limited for the quarter ended 30 September 2026 and year to date results for the period from 01 April 2026 to 30 September 2026 pursuant to Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Vijaya Diagnostic Centre Limited 1. We have reviewed the accompanying Statement of unaudited standalone financial results of Vijaya Diagnostic Centre Limited (hereinafter referred to as “the Company”) for the quarter ended 30 September 2026 and year to date results for the period from 01 April 2026 to 30 September 2026 (“the Statement”). 2. This Statement, which is the responsibility of the Company’s management and approved by its Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”). Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 5. The Company has accounted for the amalgamation of Medinova Diagnostic Services Limited (“transferor company”) with the Company during the quarter and half year ended 30 September 2025 in accordance with the Scheme of Amalgamation approved by the National Company Law Tribunal (NCLT) vide order dated 13 October 2025. The amalgamation has been accounted for by the Company by restating the financial information in the financial results in respect of the prior periods as if it had occurred from the beginning of the preceding year in the financial statements as per the requirement of Indian Accounting Standard. The corresponding figures for the quarter and half year ended 30 September 2025, in so far it pertains to the transferor company, have been reviewed by another auditor who had expressed an unmodified conclusion on 3 November 2025. Principal Office: 14th Floor, Central B Wing and North C Wing, Nesco IT Park 4, Nesco Center, Western Express Highway, Goregaon (East), Mumbai - 400063 Page 1 of 2 B S R and Co Limited Review Report (Continued) Vijaya Diagnostic Centre Limited Our conclusion is not modified in respect of this matter. For B S R and Co Chartered Accountants Firm’s Registration No.:128510W [Showing first 8,000 characters — download PDF for full document]